期刊文献+

强直性脊柱炎检测HLA-B27、ASO、RF、CRP的临床意义 被引量:3

The Clinical Significance of Testing HLA-B27、ASO、RF、CRP in Ankylosing Spondylitis
下载PDF
导出
摘要 目的探讨HLA-B27、ASO、RF、CRP检测在强直性脊柱炎(AS)诊断与鉴别诊断中的意义。方法抽取ED-TA(K2)抗凝血2ml,采用磁珠酵素免疫法检测HLA-B27,采用胶乳凝集法检测ASO、RF、CRP。结果 31例正常健康者加A-B27、ASO、RF、CRP检测结果均为阴性。108例疑似AS患者中,HLA-B27阳性率为30.6%(33/108)。33例HLA-1327阳性患者中,ASO阳性率为6.1%(2/33),RF阳性率为3.0%(1/33),CRP阳性率为12.1%(4/33)。结论 HLAA-B27的检测可明确AS诊断,特别是在不典型AS诊断中具有重要的临床价值。ASO、RF检测可用于AS的鉴别诊断。疑似AS患者HLA-B27阳性者中,其活动期的CRP比率较低。 Objective Investigate the significance of testing HLA-B27、ASO、RF、CRP in Ankylosing Spondylitis (AS) diagnosis and differential diagnosis. Method We withdraw EDTA (K2) anticoagulant blood 2ml, adopt IMS ELISE to test HLA-B27, adopt latex agglutina- tion to test ASO、RF、CRP. Results The HLA - B27、ASO、RF、CRP test result of thirty - one normal healthy are all negative. In one hun- dred and eight suspected AS patients, HLA- B27 positive rate is 30.6% (33/108). In thirty-three HLA-B27 positive patients, ASO posi- tive rate is 6.1% (2/33), RF positive rate is 3.0% (1/33), CRP positive rate is 12.1% (4/33). Conclusion The testing of HAL- B27 can diagnose AS, especially has important clinical value in diagnosis untypical AS. The testing of ASO、RF can use in the differential diagnosis of AS. In suspected HLA-B27 positive AS patients, its active stage ratio is lower.
出处 《医学研究通讯》 2004年第8期37-38,共2页 Bulletin of Medical Research
关键词 强直性脊柱炎 检测 HLA—B27 ASO RF CRP Ankylosing Spondylitis HLA-B27 ASO RF CRP
  • 相关文献

参考文献2

二级参考文献19

  • 1Liu Y, Li J, chen B,et al. Familial aggregation ankylosing spondylitis in Southern China[J]. J Rheumatol, 2001,28:550-553.
  • 2Archr J, Keat A. Ankylosing spondylitis: time to focus on ankylosis[J]. J Rheumatol, 1999,26: 761-764.
  • 3Khan M. The 21 HLA-B27 subtypes[J]. J Rheumatol,2000,27 (supp159) : 29-32.
  • 4Lamas JR, Paradela A, Roncal F, et al. Modulation at multiple anchor positions of the peptide specifity of HLAB27 subtypes differentially associated with ankylosing spondylitis[J]. Arthritis Rheum, 1999,42:1975-1985.
  • 5Khan M. A current perspective on ankylosing spondylitis and related spondyloarthropathies[J]. J Ind Rheum Asso,1999,7:16-21.
  • 6Lopez-Larrea C, Gonzalez S, Martinez-Borra J, et al. The role of HLA-B27 Polymorphism and molecular mimicry in spondyloarthropathies[J]. Molecular Med Today, 1998,4:540-549.
  • 7Ren EC, Koh WH, Sim D,et al. Possible protective role of HLA-B* 2706 for ankylosing spondylitis[J]. Tissue Antigens,1997,49:67-69.
  • 8Fiorillo MT, Maragno M, Butler R, et al. CD8 (+) T-cell antoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis [J]. J Clin Invest, 2000,106:47-51.
  • 9Brown M,Kennedy L, MacGregor A, et al. Susceptibility to ankylosing spondylitis in twins:the role of genes, HLA, and enviroment[J]. Arthritis Rheum, 1997,40: 1823-1828.
  • 10Balas A, Santos S, Garcia-Sanchez F,et al. Complete coding sequence of HLA-B* 2712 a serologic B-27-negative antigen associated to Bwb [J].Tissue Antigens, 1998,51: 394-397.

共引文献28

同被引文献11

引证文献3

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部